Skip to content
Clinical Trials – home

CIMETIDINE HYDROCHLORIDE: A Comprehensive Guide for Patients

1 / 2
trials open to patients / all trials
17+
Countries

In short

This article discusses the use of Cimetidine Hydrochloride in clinical trials for treating advanced or metastatic non-small cell lung cancer (NSCLC). The drug is being studied as part of a combination therapy with other medications to evaluate its safety, effectiveness, and potential benefits for patients with this serious condition.

At a glance

Study Type
Phase II clinical trial
Target Condition
Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Treatment
Cimetidine Hydrochloride in combination with other drugs
Primary Objectives
Evaluate safety, tolerability, and objective response rate (ORR)
Secondary Objectives
Assess duration of response, progression-free survival, overall survival, pharmacokinetics, and immunogenicity
Eligibility
Adults (18+) with confirmed advanced NSCLC, meeting specific health criteria
Study Design
Screening period, treatment period, and survival follow-up period
Treatment Duration
Until discontinuation criteria are met

What is Cimetidine Hydrochloride?

Cimetidine Hydrochloride is an active substance used in medications. It belongs to a class of drugs known as histamine-2 (H2) blockers. These medications work by reducing the amount of acid produced in the stomach.

Medical Uses

While the specific medical uses are not explicitly stated in the provided information, Cimetidine Hydrochloride is typically used to treat various conditions related to excess stomach acid, such as:

  • Gastroesophageal reflux disease (GERD): A condition where stomach acid frequently flows back into the esophagus
  • Peptic ulcers: Sores that develop on the lining of the stomach or small intestine
  • Zollinger-Ellison syndrome: A rare condition that causes tumors in the pancreas or duodenum, leading to increased stomach acid production
  • Heartburn: A burning sensation in the chest caused by stomach acid

It's important to note that the exact use may vary depending on the specific formulation and prescription.

Administration

The information provided does not specify the exact route of administration for this particular formulation of Cimetidine Hydrochloride. However, it's listed as "UNKNOWN USE" in the data. Typically, Cimetidine is available in various forms, including:

  • Oral tablets
  • Oral liquid
  • Injectable solutions

The specific form and method of administration should be determined by your healthcare provider based on your individual needs and condition.

Dosage

The dosage information for this specific formulation is not provided in the given data. The dosage can vary depending on several factors, including:

  • The condition being treated
  • The severity of the condition
  • The patient's age and overall health
  • Other medications the patient may be taking

It's crucial to follow the dosage instructions provided by your healthcare provider or as indicated on the prescription label.

Duration of Treatment

The data indicates a maximum treatment period of 75 days for this formulation of Cimetidine Hydrochloride. However, the actual duration of treatment may vary depending on your specific condition and response to the medication. Always follow your healthcare provider's instructions regarding the length of treatment.

Important Considerations

When taking Cimetidine Hydrochloride, keep the following points in mind:

  • Pediatric use: The data indicates that this is not a pediatric formulation. Always consult with a pediatrician before giving this medication to children.
  • Interactions: Cimetidine can interact with other medications. Inform your healthcare provider about all the medicines you're taking, including over-the-counter drugs and supplements.
  • Side effects: Like all medications, Cimetidine can cause side effects. Common side effects may include headache, dizziness, and diarrhea. Consult your healthcare provider if you experience any unusual or severe side effects.
  • Regular monitoring: Your healthcare provider may want to monitor your progress regularly to ensure the medication is working effectively and safely.

Remember, this information is general, and your specific treatment plan may differ. Always consult with your healthcare provider for personalized medical advice and follow their instructions carefully.

Questions people often ask

Conditions where Cimetidine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Cimetidine Hydrochloride

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).